Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lyketsos

Showing results (351-360 of 396) with videos related to

Pageof 40
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2019
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trialStephan Ehrhardt, Anton P Porsteinsson, Cynthia A Munro, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 25, 2011
Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression studyJoAnn T Tschanz, Chris D Corcoran, Sarah Schwartz, et al.
Journal of Geriatric Psychiatry and Neurology|January 10, 2012
Sertraline for the treatment of depression in Alzheimer disease: genetic influencesMatthew E Peters, Vijay Vaidya, Lea T Drye, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Extended results of the Alzheimer's disease anti-inflammatory prevention trialJohn C Breitner, Laura D Baker, Thomas J Montine, et al.
International Journal of Geriatric Psychiatry|March 1, 2012
The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's diseaseP B Rosenberg, M M Mielke, D Han, et al.
Neuroimage|April 23, 2009
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participantsKenichi Oishi, Andreia Faria, Hangyi Jiang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 4, 2012
Citalopram for agitation in Alzheimer's disease: design and methodsLea T Drye, Zahinoor Ismail, Anton P Porsteinsson, et al.
Neuroimage. Clinical|November 2, 2013
Gross feature recognition of Anatomical Images based on Atlas grid (GAIA): Incorporating the local discrepancy between an atlas and a target image to capture the features of anatomic brain MRIYuan-Yuan Qin, Johnny T Hsu, Shoko Yoshida, et al.
JAMA Neurology|July 16, 2019
Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of AgingDimitrios Kapogiannis, Maja Mustapic, Michelle D Shardell, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodologyL S Schneider, P N Tariot, C G Lyketsos, et al.
Pageof 40

Showing results (351-360 of 396) with videos related to

Sort By:
Pageof 40
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2019
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trialStephan Ehrhardt, Anton P Porsteinsson, Cynthia A Munro, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 25, 2011
Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression studyJoAnn T Tschanz, Chris D Corcoran, Sarah Schwartz, et al.
Journal of Geriatric Psychiatry and Neurology|January 10, 2012
Sertraline for the treatment of depression in Alzheimer disease: genetic influencesMatthew E Peters, Vijay Vaidya, Lea T Drye, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Extended results of the Alzheimer's disease anti-inflammatory prevention trialJohn C Breitner, Laura D Baker, Thomas J Montine, et al.
International Journal of Geriatric Psychiatry|March 1, 2012
The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's diseaseP B Rosenberg, M M Mielke, D Han, et al.
Neuroimage|April 23, 2009
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participantsKenichi Oishi, Andreia Faria, Hangyi Jiang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 4, 2012
Citalopram for agitation in Alzheimer's disease: design and methodsLea T Drye, Zahinoor Ismail, Anton P Porsteinsson, et al.
Neuroimage. Clinical|November 2, 2013
Gross feature recognition of Anatomical Images based on Atlas grid (GAIA): Incorporating the local discrepancy between an atlas and a target image to capture the features of anatomic brain MRIYuan-Yuan Qin, Johnny T Hsu, Shoko Yoshida, et al.
JAMA Neurology|July 16, 2019
Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of AgingDimitrios Kapogiannis, Maja Mustapic, Michelle D Shardell, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodologyL S Schneider, P N Tariot, C G Lyketsos, et al.
Pageof 40